{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:54:49Z","timestamp":1787018089344,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:p>\n                    The sFlt-1 (soluble fms-like tyrosine kinase-1), PlGF (placental growth factor), and their ratio are useful for predicting delivery because of preeclampsia in singleton pregnancies. Evidence on the utility of sFlt-1\/PlGF ratio in twin pregnancies is lacking. We aimed to evaluate the predictive value of sFlt-1\/PlGF ratio for delivery because of preeclampsia in twins. A retrospective data analysis of 164 twin pregnancies with suspected preeclampsia was performed. The sFlt-1\/PlGF ratio, which was known to clinicians, was significantly higher in women who delivered within 1 and 2 weeks compared with those who did not (median: 98.9 and 84.2 versus 23.5 pg\/mL, respectively;\n                    <jats:italic>P<\/jats:italic>\n                    &lt;0.001). The area under the curve values sFlt-1\/PlGF ratio levels were 0.88 (95% CI, 0.83\u20130.84) and 0.88 (95% CI, 0.83\u20130.93) for predicting delivery because of preeclampsia within 1 and 2 weeks of blood sampling, respectively. The predictive accuracy of sFlt-1\/PlGF was independent of gestational age at sampling and chorionicity (\n                    <jats:italic>P<\/jats:italic>\n                    &gt;0.100 for interaction). The area under the curve values of sFlt-1\/PlGF were significantly higher than for PlGF alone (mean 0.88 and 0.88 versus 0.81 and 0.80) for predicting delivery because of preeclampsia within 1 and 2 weeks of blood sampling (\n                    <jats:italic>P<\/jats:italic>\n                    =0.055 and 0.001, respectively). sFlt-1\/PlGF ratio lower than 38 was able to rule-out delivery within 1 and 2 weeks with a negative predictive value of 98.8% and 96.4% for delivery because of preeclampsia within 1 and 2 weeks, respectively. A cutoff of 38 is applicable for ruling out delivery because of preeclampsia in twin pregnancies.\n                  <\/jats:p>","DOI":"10.1161\/hypertensionaha.120.14957","type":"journal-article","created":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T05:00:28Z","timestamp":1590469228000},"page":"176-183","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":41,"title":["The Prognostic Value of Angiogenic Markers in Twin Pregnancies to Predict Delivery Due to Maternal Complications of Preeclampsia"],"prefix":"10.1161","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5725-9270","authenticated-orcid":false,"given":"Julia","family":"Binder","sequence":"first","affiliation":[{"name":"From the Department of Obstetrics and Fetomaternal Medicine, Medical University of Vienna, Austria (J.B., P. Palmrich, P. Pateisky, L.K., H.Z., M.M., K.W.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Palmrich","sequence":"additional","affiliation":[{"name":"From the Department of Obstetrics and Fetomaternal Medicine, Medical University of Vienna, Austria (J.B., P. Palmrich, P. Pateisky, L.K., H.Z., M.M., K.W.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Pateisky","sequence":"additional","affiliation":[{"name":"From the Department of Obstetrics and Fetomaternal Medicine, Medical University of Vienna, Austria (J.B., P. Palmrich, P. Pateisky, L.K., H.Z., M.M., K.W.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkan","family":"Kalafat","sequence":"additional","affiliation":[{"name":"Department of Statistics, Faculty of Arts and Sciences, Middle East Technical University Ankara, Turkey (E.K.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz","family":"Kuessel","sequence":"additional","affiliation":[{"name":"From the Department of Obstetrics and Fetomaternal Medicine, Medical University of Vienna, Austria (J.B., P. Palmrich, P. Pateisky, L.K., H.Z., M.M., K.W.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Zeisler","sequence":"additional","affiliation":[{"name":"From the Department of Obstetrics and Fetomaternal Medicine, Medical University of Vienna, Austria (J.B., P. Palmrich, P. Pateisky, L.K., H.Z., M.M., K.W.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"March","family":"Munkhbaatar","sequence":"additional","affiliation":[{"name":"From the Department of Obstetrics and Fetomaternal Medicine, Medical University of Vienna, Austria (J.B., P. Palmrich, P. Pateisky, L.K., H.Z., M.M., K.W.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Windsperger","sequence":"additional","affiliation":[{"name":"From the Department of Obstetrics and Fetomaternal Medicine, Medical University of Vienna, Austria (J.B., P. Palmrich, P. Pateisky, L.K., H.Z., M.M., K.W.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basky","family":"Thilaganathan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Ankara University, Turkey (E.K.)"},{"name":"Fetal Medicine Unit, St George\u2019s Hospital, St George\u2019s University of London, United Kingdom (B.T., A.K.)"},{"name":"Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St George\u2019s University of London (B.T., A.K.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Khalil","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Ankara University, Turkey (E.K.)"},{"name":"Fetal Medicine Unit, St George\u2019s Hospital, St George\u2019s University of London, United Kingdom (B.T., A.K.)"},{"name":"Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St George\u2019s University of London (B.T., A.K.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(14)70227-X"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.15578"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.15427"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.10803"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/uog.20417"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2019.03.024"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/uog.20224"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2006.00908.x"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.054361"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13997"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.12760"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.12205"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13763"},{"key":"e_1_3_3_15_2","unstructured":"AWMF. Hypertensive schwangerschaftserkrankungen: diagnostik und therapie. 2019. Available at: www.awmf.org\/leitlinien\/detail\/ll\/015-018.html. Accessed February 2020."},{"key":"e_1_3_3_16_2","unstructured":"National Institute for Health and Care Excellence. Hypertension in pregnancy: diagnosis and management (Clinical Guideline NG133). 2019. Available at: https:\/\/www.nice.org.uk\/guidance\/ng133. Accessed February 2020."},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.112.195065"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2014.11.035"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/uog.14760"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2018.03.014"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2014.02.001"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/uog.19013"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0029-7844(98)00052-0"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9010183"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/uog.18894"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1414838"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.120.14957","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T06:42:52Z","timestamp":1715582572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.120.14957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.120.14957"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.120.14957","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"2020-02-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}